The vascular endothelium masks the persistent inhibition of rat thoracic arterial tone induced by S-nitrosoglutathione

Cardiovascular Journal of Africa

Volumn 22, Issue 1, 2011, Pages 7-13

  Sarr, M ^a,b   Sar, F B ^a,b   Gueye, L ^a,b   Kane, M O ^a   Wele, A ^a   Diallo, A S ^a   Schini Kerth, V ^c   Muller, B ^d  

^a UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c Faculté de Pharmacie   (France)

^d INSERM   (France)

Author keywords

Endothelium; Nitric oxide; S nitrosoglutathione

Indexed keywords

ACETYLCYSTEINE; GUANYLATE CYCLASE; LOW MOLECULAR WEIGHT KININOGEN; NACOLOMAB TAFENATOX; NITRIC OXIDE DONOR; NORADRENALIN; S NITROSOGLUTATHIONE; VASOCONSTRICTOR AGENT; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN; S NITROSOTHIOL; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CONFOCAL MICROSCOPY; ISOMETRICS; MALE; NITROSYLATION; NONHUMAN; RAT; VASCULAR ENDOTHELIUM; VASCULAR RING; ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY TONE; CONTROLLED STUDY; DRUG MECHANISM; MUSCLE ISOMETRIC CONTRACTION; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GUANYLATE CYCLASE; MALE; MICROSCOPY, CONFOCAL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; S-NITROSOGLUTATHIONE; SULFHYDRYL COMPOUNDS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 79951638365     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol 2001; 38 (Suppl 2): S11-14.
2. Higashi Y, Yoshizumi M. New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and -independent vasodilation. J Pharmacol Sci 2003; 93(4): 399-404. (Pubitemid 38195306)
3. Maxwell AJ. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 2002; 6(2): 101-124. (Pubitemid 34848433)
4. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 2003; 108(17): 2034-2040. (Pubitemid 37337574)
5. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327(6122): 524-526. (Pubitemid 17085822)
6. Sarr M, Chataigneau M, Etienne-Selloum N, Diallo AS, Schott C, Geffard M, et al. Targeted and persistent effects of NO mediated by S-nitrosation of tissue thiols in arteries with endothelial dysfunction. Nitric Oxide 2007; 17(1): 1-9. (Pubitemid 47064427)
7. Sarr M, Chataigneau M, Martins S, Schott C, El Bedoui J, Oak MH, et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 2006; 71(4): 794-802. (Pubitemid 44848291)
8. Sarr M, Lobysheva I, Diallo AS, Stoclet JC, Schini-Kerth VB, Muller B. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate. Eur J Pharmacol 2005; 513(1-2): 119-123. (Pubitemid 40692252)
9. Alencar JL, Lobysheva I, Chalupsky K, Geffard M, Nepveu F, Stoclet JC, Muller B. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries. J Pharmacol Exp Ther 2003; 307(1): 152-159. (Pubitemid 37151901)
10. Marin J, Rodriguez-Martinez MA. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther 1997; 75(2): 111-134. (Pubitemid 27521027)
11. Megson IL, Webb DJ. Nitric oxide donor drugs: current status and future trends. Expert Opin Investig Drugs 2002; 11(5): 587-601. (Pubitemid 34520612)
12. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 2002; 90(1): 21-28. (Pubitemid 34074604)
13. Alencar JL, Lobysheva I, Geffard M, Sarr M, Schott C, Schini-Kerth VB, et al. Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone. Mol Pharmacol 2003; 63(5): 1148-1158. (Pubitemid 36529933)
14. Alencar JL, Chalupsky K, Sarr M, Schini-Kerth V, Vanin AF, Stoclet JC, et al. Inhibition of arterial contraction by dinitrosyl-iron complexes: critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation. Biochem Pharmacol 2003; 66(12): 2365-2374. (Pubitemid 37456744)
15. Terluk MR, da Silva-Santos JE, Assreuy J. Involvement of soluble guanylate cyclase and calcium-activated potassium channels in the long-lasting hyporesponsiveness to phenylephrine induced by nitric oxide in rat aorta. Naunyn Schmiedebergs Arch Pharmacol 2000; 361(5): 477-483. (Pubitemid 30262595)
16. Megson IL, Chalupsky K, Sarr M, Schini-Kerth V, Vanin AF, Stoclet JC, et al. N-Substituted analogues of S-nitroso-N-acetyl-D, L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries. Br J Pharmacol 1999; 126(3): 639-648. (Pubitemid 29087842)
17. Megson IL, Greig IR, Gray GA, Webb DJ, Butler AR. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug. Br J Pharmacol 1997; 122(8): 1617-1624. (Pubitemid 28000188)
18. Olson LJ, Knych ET, Jr, Herzig TC, Drewett JG. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension 1997; 9(1 Pt 2): 254-261. (Pubitemid 27074052)
19. Hwang TL, Wu CC, Teng CM. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea. Br J Pharmacol 1998; 125(6): 1158-1163.
20. Muller B, Kleschyov AL, Malblanc S, Stoclet JC. Nitric oxide-related cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopolysaccharide-treated rat aorta. Br J Pharmacol 1998; 123(6): 1221-1229. (Pubitemid 28120522)
21. Hussain AS, Marks GS, Brien JF, Nakatsu K. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can J Physiol Pharmacol 1997; 75(8): 1034-1037. (Pubitemid 27487963)
22. Wang YX, Poon CI, Pang CC. Vascular pharmacodynamics of NG-nitro-L-arginine methyl ester in vitro and in vivo. J Pharmacol Exp Ther 1993; 267(3): 1091-1099. (Pubitemid 24068670)
23. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101(3): 746-752. (Pubitemid 20357206)
24. Sayed N, Kim DD, Fioramonti X, Iwahashi T, Duran WN, Beuve A. Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ Res, 2008. 103(6): 606-614.
25. Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 2007; 104(30): 12312-12317. (Pubitemid 47206134)
26. Fernandes D, Assreuy J. Nitric oxide and vascular reactivity in sepsis. Shock 2008; 30 (Suppl 1): 10-13.
27. Carrier GO, Fuchs LC, Winecoff AP, Giulumian AD, White RE. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am J Physiol 1997; 273(1 Pt 2): H76-84.
28. Hansen PR, Olesen SP. Relaxation of rat resistance arteries by acetylcholine involves a dual mechanism: activation of K+ channels and formation of nitric oxide. Pharmacol Toxicol 1997; 80(6): 280-285. (Pubitemid 27264821)
29. + channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 1998; 124(6): 1131-1140.
30. Batenburg WW, de Vries R, Saxena PR, Danser AH. L-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries? J Hypertens 2004; 22(10): 1927-1936. (Pubitemid 39336675)